MIROCALS - Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosedAmyotrophic Lateral Sclerosis (ALS) patients

Project: Research

Project Details

StatusFinished
Effective start/end date1/09/201530/09/2021

Collaborative partners

Funding

  • EC European Commission: £387,723.00